Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132676 · ClinicalTrials.gov registry record
Shared Health Appointments and Reciprocal Enhanced Support
A clinical trial of Diabetes Insipidus, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 1,536
- Enrollment target
- 5
- Study locations
NCT02132676: Completed study of Diabetes Insipidus, sponsored by VA Office of Research and Development.
NCT02132676 is a study of Diabetes Insipidus that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,536 participants. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02132676, a study of Diabetes Insipidus, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 1,536 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of diabetes in five VA health systems, and to study the implementation process in order to gather information required to disseminate the program more broadly in the VHA system.
Primary Outcome
Glycemic control (measured by Hemoglobin A1c) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values of A1c, the investigators will also examine the change in the percentage of patients with an average A1c \> 8%.
Conditions Studied
Study Locations (5)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA Northern California Health Care System, Mather, CA - Sacramento
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Rhode Island
- Providence VA Medical Center, Providence, RI - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,536 participants |
| Start Date | 2016-04-25 |
| Est. Completion | 2019-07-30 |
What the finished NCT02132676 record still lists
NCT02132676 is an observational study that tracks outcomes without assigning an intervention. Its 1,536 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Diabetes Insipidus appearing as the primary indexed condition, and to 0 interventions.
NCT02132676 lists 5 locations in 4 states (California, Connecticut, Michigan).
Frequently Asked Questions
What is clinical trial NCT02132676 about?
NCT02132676 is a clinical study titled "Shared Health Appointments and Reciprocal Enhanced Support". The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of diabetes in five VA health systems, and to study the implementation process in order to gather information required...
What is the current status of trial NCT02132676?
This trial is currently completed. The enrollment target is 1,536 participants. The study started on 2016-04-25. Estimated completion is 2019-07-30.
What conditions does trial NCT02132676 study?
This clinical trial studies the following conditions: Diabetes Insipidus.
Who is sponsoring clinical trial NCT02132676?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02132676 being conducted?
This trial has 5 study locations across California, Connecticut, Michigan, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Insipidus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06842875 · 1,536 participants · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06393374 · 1,530 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- NCT07114510 · 1,530 participants · NA
Optimal Ventilation for Cardiac Arrest
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI